Skip to main content
PMC home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 2000 Jun;37(6):415–421. doi: 10.1136/jmg.37.6.415

FRAXA and FRAXE: the results of a five year survey

S Youings 1, A Murray 1, N Dennis 1, S Ennis 1, C Lewis 1, N McKechnie 1, M Pound 1, A Sharrock 1, P Jacobs 1
PMCID: PMC1734610  PMID: 10851251

Abstract

We report the results of a five year survey of FRAXA and FRAXE mutations among boys aged 5 to 18 with special educational needs (SEN) related to learning disability. We tested their mothers using the X chromosome not transmitted to the son as a control chromosome, and the X chromosome inherited by the son to provide information on stability of transmission. We tested 3738 boys and 2968 mothers and found 20 FRAXA and one FRAXE full mutations among the boys and none among the mothers. This gives an estimated prevalence of full mutations in males of 1 in 5530 for FRAXA and 1 in 23 423 for FRAXE.
We found an excess of intermediate and premutation alleles for both FRAXA and FRAXE. For FRAXA this was significant at the 0.001 level but the excess for FRAXE was significant only at the 0.03 level. We conclude that the excess of intermediate and premutation sized alleles for FRAXA may well be a contributing factor to the boys' mental impairment, while that for FRAXE may be a chance finding.
We studied approximately 3000 transmissions from mother to son and found five instabilities of FRAXA in the common or intermediate range and three instabilities of FRAXE in the intermediate range. Thus instabilities in trinucleotide repeat size for FRAXA and FRAXE are rare, especially among alleles in the common size range.


Keywords: FRAX syndromes; incidence; intermediate alleles; stability

Full Text

The Full Text of this article is available as a PDF (114.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrams M. T., Doheny K. F., Mazzocco M. M., Knight S. J., Baumgardner T. L., Freund L. S., Davies K. E., Reiss A. L. Cognitive, behavioral, and neuroanatomical assessment of two unrelated male children expressing FRAXE. Am J Med Genet. 1997 Feb 21;74(1):73–81. doi: 10.1002/(sici)1096-8628(19970221)74:1<73::aid-ajmg16>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  2. Allingham-Hawkins D. J., Babul-Hirji R., Chitayat D., Holden J. J., Yang K. T., Lee C., Hudson R., Gorwill H., Nolin S. L., Glicksman A. Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data. Am J Med Genet. 1999 Apr 2;83(4):322–325. [PMC free article] [PubMed] [Google Scholar]
  3. Allingham-Hawkins D. J., Ray P. N. FRAXE expansion is not a common etiological factor among developmentally delayed males. Am J Hum Genet. 1995 Jul;57(1):72–76. [PMC free article] [PubMed] [Google Scholar]
  4. Brown W. T., Houck G. E., Jr, Jeziorowska A., Levinson F. N., Ding X., Dobkin C., Zhong N., Henderson J., Brooks S. S., Jenkins E. C. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. JAMA. 1993 Oct 6;270(13):1569–1575. [PubMed] [Google Scholar]
  5. Brown W. T. The FRAXE Syndrome: is it time for routine screening? Am J Hum Genet. 1996 May;58(5):903–905. [PMC free article] [PubMed] [Google Scholar]
  6. Crawford D. C., Meadows K. L., Newman J. L., Taft L. F., Pettay D. L., Gold L. B., Hersey S. J., Hinkle E. F., Stanfield M. L., Holmgreen P. Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large, ethnically diverse, special education-needs population. Am J Hum Genet. 1999 Feb;64(2):495–507. doi: 10.1086/302260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Haddad L. A., Aguiar M. J., Costa S. S., Mingroni-Netto R. C., Vianna-Morgante A. M., Pena S. D. Fully mutated and gray-zone FRAXA alleles in Brazilian mentally retarded boys. Am J Med Genet. 1999 May 28;84(3):198–201. doi: 10.1002/(sici)1096-8628(19990528)84:3<198::aid-ajmg5>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  8. Hamerton J. L., Canning N., Ray M., Smith S. A cytogenetic survey of 14,069 newborn infants. I. Incidence of chromosome abnormalities. Clin Genet. 1975 Oct;8(4):223–243. doi: 10.1111/j.1399-0004.1975.tb01498.x. [DOI] [PubMed] [Google Scholar]
  9. Holden J. J., Julien-Inalsingh C., Chalifoux M., Wing M., Scott E., Fidler K., Swift I., Maidment B., Knight S. J., Davies K. E. Trinucleotide repeat expansion in the FRAXE locus is not common among institutionalized individuals with non-specific developmental disabilities. Am J Med Genet. 1996 Aug 9;64(2):420–423. doi: 10.1002/(SICI)1096-8628(19960809)64:2<420::AID-AJMG37>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]
  10. Holinski-Feder E., Chahrokh-Zadeh S., Jedele K. B., Meindl A., Steinbach P., Wöhrle D. FRAXE testing. Am J Hum Genet. 1996 Nov;59(5):1168–1169. [PMC free article] [PubMed] [Google Scholar]
  11. Jacobs P. A., Bullman H., Macpherson J., Youings S., Rooney V., Watson A., Dennis N. R. Population studies of the fragile X: a molecular approach. J Med Genet. 1993 Jun;30(6):454–459. doi: 10.1136/jmg.30.6.454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Knight S. J., Flannery A. V., Hirst M. C., Campbell L., Christodoulou Z., Phelps S. R., Pointon J., Middleton-Price H. R., Barnicoat A., Pembrey M. E. Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell. 1993 Jul 16;74(1):127–134. doi: 10.1016/0092-8674(93)90300-f. [DOI] [PubMed] [Google Scholar]
  13. Knight S. J., Ritchie R. J., Chakrabarti L., Cross G., Taylor G. R., Mueller R. F., Hurst J., Paterson J., Yates J. R., Dow D. J. A study of FRAXE in mentally retarded individuals referred for fragile X syndrome (FRAXA) testing in the United Kingdom. Am J Hum Genet. 1996 May;58(5):906–913. [PMC free article] [PubMed] [Google Scholar]
  14. Knight S. J., Voelckel M. A., Hirst M. C., Flannery A. V., Moncla A., Davies K. E. Triplet repeat expansion at the FRAXE locus and X-linked mild mental handicap. Am J Hum Genet. 1994 Jul;55(1):81–86. [PMC free article] [PubMed] [Google Scholar]
  15. MacDonald M., Hassold T., Harvey J., Wang L. H., Morton N. E., Jacobs P. The origin of 47,XXY and 47,XXX aneuploidy: heterogeneous mechanisms and role of aberrant recombination. Hum Mol Genet. 1994 Aug;3(8):1365–1371. doi: 10.1093/hmg/3.8.1365. [DOI] [PubMed] [Google Scholar]
  16. Mornet E., Chateau C., Simon-Bouy B., Serre J. L. The intermediate alleles of the fragile X CGG repeat in patients with mental retardation. Clin Genet. 1998 Mar;53(3):200–201. doi: 10.1111/j.1399-0004.1998.tb02676.x. [DOI] [PubMed] [Google Scholar]
  17. Morton J. E., Bundey S., Webb T. P., MacDonald F., Rindl P. M., Bullock S. Fragile X syndrome is less common than previously estimated. J Med Genet. 1997 Jan;34(1):1–5. doi: 10.1136/jmg.34.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mulley J. C., Yu S., Loesch D. Z., Hay D. A., Donnelly A., Gedeon A. K., Carbonell P., López I., Glover G., Gabarrón I. FRAXE and mental retardation. J Med Genet. 1995 Mar;32(3):162–169. doi: 10.1136/jmg.32.3.162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Murray A., Youings S., Dennis N., Latsky L., Linehan P., McKechnie N., Macpherson J., Pound M., Jacobs P. Population screening at the FRAXA and FRAXE loci: molecular analyses of boys with learning difficulties and their mothers. Hum Mol Genet. 1996 Jun;5(6):727–735. doi: 10.1093/hmg/5.6.727. [DOI] [PubMed] [Google Scholar]
  20. Patsalis P. C., Sismani C., Hettinger J. A., Boumba I., Georgiou I., Stylianidou G., Anastasiadou V., Koukoulli R., Pagoulatos G., Syrrou M. Molecular screening of fragile X (FRAXA) and FRAXE mental retardation syndromes in the Hellenic population of Greece and Cyprus: incidence, genetic variation, and stability. Am J Med Genet. 1999 May 28;84(3):184–190. [PubMed] [Google Scholar]
  21. Rousseau F., Heitz D., Biancalana V., Blumenfeld S., Kretz C., Boué J., Tommerup N., Van Der Hagen C., DeLozier-Blanchet C., Croquette M. F. Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N Engl J Med. 1991 Dec 12;325(24):1673–1681. doi: 10.1056/NEJM199112123252401. [DOI] [PubMed] [Google Scholar]
  22. Teague J. W., Morton N. E., Dennis N. R., Curtis G., McKechnie N., Macpherson J. N., Murray A., Pound M. C., Sharrock A. J., Youings S. A. FRAXA and FRAXE: evidence against segregation distortion and for an effect of intermediate alleles on learning disability. Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):719–724. doi: 10.1073/pnas.95.2.719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Turner G., Robinson H., Laing S., Purvis-Smith S. Preventive screening for the fragile X syndrome. N Engl J Med. 1986 Sep 4;315(10):607–609. doi: 10.1056/NEJM198609043151002. [DOI] [PubMed] [Google Scholar]
  24. Turner G., Webb T., Wake S., Robinson H. Prevalence of fragile X syndrome. Am J Med Genet. 1996 Jul 12;64(1):196–197. doi: 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G. [DOI] [PubMed] [Google Scholar]
  25. Verkerk A. J., Pieretti M., Sutcliffe J. S., Fu Y. H., Kuhl D. P., Pizzuti A., Reiner O., Richards S., Victoria M. F., Zhang F. P. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 1991 May 31;65(5):905–914. doi: 10.1016/0092-8674(91)90397-h. [DOI] [PubMed] [Google Scholar]
  26. Webb T. P., Bundey S., Thake A., Todd J. The frequency of the fragile X chromosome among schoolchildren in Coventry. J Med Genet. 1986 Oct;23(5):396–399. doi: 10.1136/jmg.23.5.396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Yu S., Pritchard M., Kremer E., Lynch M., Nancarrow J., Baker E., Holman K., Mulley J. C., Warren S. T., Schlessinger D. Fragile X genotype characterized by an unstable region of DNA. Science. 1991 May 24;252(5009):1179–1181. doi: 10.1126/science.252.5009.1179. [DOI] [PubMed] [Google Scholar]
  28. Zhong N., Ju W., Curley D., Wang D., Pietrofesa J., Wu G., Shen Y., Pang C., Poon P., Liu X. A survey of FRAXE allele sizes in three populations. Am J Med Genet. 1996 Aug 9;64(2):415–419. doi: 10.1002/(SICI)1096-8628(19960809)64:2<415::AID-AJMG36>3.0.CO;2-G. [DOI] [PubMed] [Google Scholar]
  29. de Vries B. B., Mohkamsing S., van den Ouweland A. M., Mol E., Gelsema K., van Rijn M., Tibben A., Halley D. J., Duivenvoorden H. J., Oostra B. A. Screening for the fragile X syndrome among the mentally retarded: a clinical study. The Collaborative Fragile X Study Group. J Med Genet. 1999 Jun;36(6):467–470. [PMC free article] [PubMed] [Google Scholar]
  30. de Vries B. B., van den Ouweland A. M., Mohkamsing S., Duivenvoorden H. J., Mol E., Gelsema K., van Rijn M., Halley D. J., Sandkuijl L. A., Oostra B. A. Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study Group. Am J Hum Genet. 1997 Sep;61(3):660–667. doi: 10.1086/515496. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES